-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QDcs1+KdscDAZih4xJuddpz06A+Y6JxUCBRMyZ11DIXjsg3skLYxf4w8JK/8PMj+ gYQnK6yuSMGvbLQKxpE94Q== 0000950133-03-001993.txt : 20030523 0000950133-03-001993.hdr.sgml : 20030523 20030523115114 ACCESSION NUMBER: 0000950133-03-001993 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030522 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20030523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALION SCIENCE & TECHNOLOGY CORP CENTRAL INDEX KEY: 0001166568 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 542061691 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-89756 FILM NUMBER: 03717564 BUSINESS ADDRESS: STREET 1: 1750 TYSONS BLVD STREET 2: STE 1300 CITY: MCLEAN STATE: VA ZIP: 22102 BUSINESS PHONE: 7039184480 FORMER COMPANY: FORMER CONFORMED NAME: BEAGLE HOLDINGS INC DATE OF NAME CHANGE: 20020205 8-K 1 w87023e8vk.htm CURRENT REPORT e8vk
 

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549


FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 22, 2003

ALION SCIENCE AND TECHNOLOGY CORPORATION
(Exact Name of Registrant as Specified in its Charter)
         
Delaware   333-89756   54-2061691

 
 
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)
     
10 West 35th Street   1750 Tysons Boulevard
Chicago, IL 60616   Suite 1300
(312) 567-4000   McLean, VA 22102
    (703) 918-4480


(Address, including Zip Code and Telephone Number, including
Area Code, of Principal Executive Offices)

 


 

Item 7. Financial Statements, Pro Forma Financial Information, and Exhibits.

(c)  Exhibits

     
Exhibit Number                                     Description
 
99   Press Release dated May 22, 2003, announcing Alion’s financial results for the second 12-week interim period ended March 14, 2003 and the 24-week period ended March 14, 2003.

Item 9. Regulation FD Disclosure (Required by Item 12. Results of Operations and Financial Condition).

On May 22, 2003, Alion Science and Technology Corporation issued a final press release announcing financial results for the second 12-week interim period ended March 14, 2003 and the 24-week period ended March 14, 2003. This press release is attached as Exhibit 99 to this Current Report on Form 8-K.

In accordance with the procedural guidance in SEC Release No. 33-8216, the information in this Form 8-K and the Exhibit attached hereto is being furnished under “Item 9. Regulation FD Disclosure” rather than under “Item 12. Results of Operations and Financial Condition.” The information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

2


 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 23, 2003
 
ALION SCIENCE AND TECHNOLOGY CORPORATION
 
By: /s/ John M. Hughes         
Name: John M. Hughes
Title: Chief Financial Officer

3 EX-99 3 w87023exv99.htm EXHIBIT 99 exv99

 

EXHIBIT 99

Alion Science and Technology Corporation Issues Final Announcement of Results for the Fiscal Year 2003 Second 12-week Interim Period Ending March 14, 2003 and the 24-Week Period Ending March 14, 2003.

McLean, VA, May 22, 2003. Alion Science and Technology Corporation today announced its operating results for the second 12-week interim period and the 24-week period ended March 14, 2003.

The following discussion is based on pro forma financial results for the periods described, as if Alion’s acquisition of substantially all of the assets of IIT Research Institute (IITRI) on December 20, 2002 had been consummated on the Company’s first day of each fiscal year.

Revenue for the second 12-week interim period ended March 14, 2003 increased 9.1% to $49.0 million, compared with $44.9 million for the second 12-week interim period ended March 15, 2002. The increase in revenue was largely a result of expanded services under the Modeling and Simulation Information Analysis Center (MSIAC) contract with the Department of Defense; an increase in demilitarization support services to the U.S. Army’s Newport Chemical Agent Disposal Facility (NECDF); and additional support to the Department of Defense Joint Spectrum Center (JSC).

On a normalized basis, excluding the non-recurring transaction expenses and the amortization expenses related to the purchased contract costs from IITRI noted below, income from operations for the 12-week interim period ended March 14, 2003, would have been $2.0 million, compared to income from operations of $2.6 million for the comparable period last year. This decline was due, in part, to increases in indirect expenses related to one-time costs for new SEC reporting requirements and the establishment of ESOP management infrastructure and one-time costs, such as advertising, branding and internal network conversion expenses, related to the transition from IITRI to Alion, as well as normal increases in overhead and general and administrative expenses in support of the increased size and complexity of Alion’s business. (1)

The non-recurring expenses, which were excluded from the results discussed in the previous paragraph, consist of transaction expenses related to Alion’s purchase of substantially all of the assets of IITRI in the amounts of $0.4 million and $1.1 million, respectively, for the 12-week interim periods ending March 14, 2003 and March 15, 2002. The amortization expenses for intangible assets acquired in the transaction totaled approximately $2.4 million in each of the comparable 12-week interim periods. When these transaction and amortization expenses are included (as required by U.S. generally accepted accounting principles), the loss from operations was $0.8 million for the 12-week interim period ended March 14, 2003, compared with the loss from operations of $0.9 million for the comparable period in 2002. The net loss for the second 12-week interim period in 2003 was $3.1 million, which is comparable to the net loss of $3.2 million for the similar period last year, due to the items stated above.

Revenue for the 24-week interim period ended March 14, 2003 increased $7.7 million to $96.3 million, up 8.7%, when compared with the comparable interim period ended March 15, 2002. The increase in revenue resulted from expanded business under the three contracts described in the 12-week revenue discussion above. The increase in revenue was partially offset by a revenue reduction of $0.6 million related to certain additional costs on a fixed price contract and non-reimbursable, fully-burdened direct costs on a cost-reimbursement contract.

On a normalized basis, excluding non-recurring transaction expenses and amortization expenses related to the purchased contract costs from IITRI, income from operations for the 24-week period ended March 14, 2003, would have been $3.8 million, compared to $4.6 million for the comparable period last year. This decline was due, in part, to increases in indirect expenses related to one-time costs for new SEC reporting requirements and the establishment of ESOP management infrastructure and one-time costs, such as advertising, branding and internal network conversion expenses, related to the transition from IITRI to Alion, as well as normal increases in overhead and general and administrative expenses in support of the increased size and complexity of Alion’s business. (1)

The non-recurring expenses, which were excluded from the results discussed in the previous paragraph, consist of $5.8 million and $1.1 million, respectively, of transaction expenses for the 24-week interim periods ended March 14, 2003 and March 15, 2002, which are related to Alion’s purchase of substantially all of the assets of IITRI. The amortization expenses were approximately $4.7 million in both 24-week periods, for intangible assets acquired in the transaction. When these transaction and amortization expenses are included (as required by U.S. generally accepted accounting principles), the loss from operations for the 24-week interim period ended March 14, 2003 was $6.7 million, compared to a loss from operations of $1.2 million for the comparable period in 2002. The net loss for the 24-week period ended March 14, 2003, compared to the 24-week period ended March 15, 2002, was $11.2 million and $6.0 million, respectively, due to the items stated above.

1


 

Commenting on the second interim period of 2003, Alion Chairman and CEO Bahman Atefi stated, “I am pleased with the progress we have made through the first half of our fiscal year, and look forward to continued expansion of our business in the last two quarters. Recent increases in funded backlog and associated requirements for increases in direct charge staffing bode well for the near-term expansion of our revenue base.”

Through the 24-week interim period ended March 14, 2003, Alion derived 98% of its revenue from federal government contracts on which it serves as either prime contractor or subcontractor. For the comparable period in 2002, Alion derived 97% of its revenue from federal government contracts. Revenue from the Department of Defense accounted for approximately 94% of revenue through the end of the second interim period ended March 14, 2003, up from approximately 89% for the comparable period in 2002.

Commenting on the second interim period, Alion Senior Vice President and CFO Jack Hughes said, “I am happy to report that much of the one-time costs, described above, that relate to the transition from IITRI to Alion and to the new infrastructure required for SEC reporting and establishment of the ESOP are now behind us. I am expecting improvements in cost efficiency, giving rise to increased profitability as we move through the latter half of this fiscal year. We have also begun the “de-leveraging” process to reduce Alion’s transaction-related debt, having made our first installment payment of principal on our senior term note in mid-March.”

This press release contains information about management’s view of Alion’s future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, changes to the ERISA laws related to Alion’s Employee Ownership, Savings and Investment Plan; changes to the tax laws relating to the treatment and deductibility of goodwill, Alion’s subchapter S status, or any change in Alion’s effective tax rate; additional costs associated with compliance with the Sarbanes-Oxley Act of 2002, including any changes in the SEC’s rules, and other corporate governance requirements; failure of government customers to exercise options under contracts; funding decisions relating to U.S. Government projects; government contract procurement (such as bid protest) and termination risks; competitive factors such as pricing pressures and/or competition to hire and retain employees; the results of current and/or future legal proceedings and government proceedings which may arise out of our operations (including our contracts with government agencies) and the attendant risks of fines, liabilities, penalties, suspension and/or debarment; material changes in laws or regulations applicable to Alion’s businesses; and other risk factors and uncertainties discussed in Alion’s Form 10-Q, filed with the SEC on April 28, 2003, in its registration statement on Form S-1 filed with the SEC on March 24, 2003, and in other documents periodically filed with the SEC.

Note: (1) Normalized income from operations is defined as income from operations, which is a standard U.S. generally accepted accounting principles (“GAAP”) measurement, plus non-recurring transaction expenses and amortization expenses, both of which are directly related to the purchase by Alion of substantially all of the assets and certain liabilities of the Illinois Institute of Technology Research Institute (IITRI) on December 20, 2002. Alion’s management has provided the normalized income from operations analysis in this press release, because we believe it provides our beneficial employee-owners a more meaningful measure of financial performance as well as a better understanding of operating results, particularly when comparing our financial results to-date to our operating financial plan for the same period of time. Normalized income from operations should not be construed as an alternative to income from operations, as calculated pursuant to GAAP.

2


 

ALION SCIENCE AND TECHNOLOGY CORPORATION
Pro Forma Consolidated Statements of Operations
For the 12-Week and 24-Week Periods Ended March 14, 2003 and March 15, 2002
(In thousands, except share information)
(Unaudited)

                                     
        Pro Forma   Pro Forma
        For the 12-week Period   For the 24-week Period
        Ended   Ended   Ended   Ended
        March 14, 2003   March 15, 2002   March 14, 2003 March 15, 2002
       
 
 

Contract revenue
  $ 49,005     $ 44,852     $ 96,270     $ 88,554  
Direct contract expenses
    36,031       32,838       70,686       64,923  
 
   
     
     
     
 
   
Gross profit
    12,974       12,014       25,584       23,631  
 
   
     
     
     
 
Operating expenses:
                               
 
Indirect contract expenses
    2,848       2,249       5,416       4,794  
 
Research and development
    19       114       55       205  
 
General and administrative
    5,432       4,710       10,746       9,373  
 
Nonrecurring transaction costs
    388       1,078       5,836       1,078  
 
Rental and occupancy expense
    2,093       1,981       4,294       3,846  
 
Depreciation and amortization
    2,819       2,789       5,702       5,548  
 
Bad debt expenses
    155       6       275       9  
 
   
     
     
     
 
Total operating expenses
    13,754       12,927       32,324       24,853  
 
   
     
     
     
 
   
Operating loss
    (780 )     (913 )     (6,740 )     (1,222 )
Other expense:
                               
 
Interest income
    3       13       25       15  
 
Interest expense
    (2,223 )     (2,178 )     (4,377 )     (4,335 )
 
Other
    (75 )     19       (96 )     (56 )
 
   
     
     
     
 
   
Loss before income taxes
    (3,075 )     (3,059 )     (11,188 )     (5,598 )
 
Income tax expense
          (159 )     (27 )     (366 )
   
Net loss
  $ (3,075 )   $ (3,218 )   $ (11,215 )   $ (5,964 )
 
   
     
     
     
 
Pro forma basic and diluted loss per share   $ (1.19 )   $ (1.25 )   $ (4.35 )   $ (2.32 )
 
   
     
     
     
 
Pro forma basic and diluted weighted average commmon shares outstanding     2,575,508       2,575,508       2,575,508       2,575,508  

3


 

Revenue by Customer Type

The following table sets forth, for each period indicated, the percentage of our revenues derived from each of our major types of customers.

                   
      For the 24-week period ended
     
      March 15, 2002   March 14, 2003
     
 
Department of Defense
    93.6 %     89.2 %
Federal Civilian Agencies
    4.7       7.8  
Commercial / State / Local
    1.7       3.0  
 
   
     
 
 
Total
    100.0 %     100.0 %
 
   
     
 
                 
    Balance Sheet Data
    (dollars in millions)
    March 14, 2003   September 30, 2003
   
 
Current assets
  $ 53     $ 7  
Current liabilities
    37       97  
Working capital
    16       (90 )
Total debt
    101       11  
Shareholders’ equity
    23       (90 )
Total assets
    151       7  

4 -----END PRIVACY-ENHANCED MESSAGE-----